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Abstract: The objective of this study is to measure the preliminary efficacy of a pilot intervention,
grounded in behavioural economics, increasing adherence of dual protection (simultaneous use of effective
modern contraception and a barrier method, such as a condom) to protect against HIV, other sexually
transmitted infections, and unintended pregnancy. Between 2015 and 2016, 100 women aged 18–40 years,
seeking post-abortion care in Cape Town, South Africa were recruited to Empower Nudge, a randomised
controlled trial to test a lottery incentive intervention designed to increase dual protection. At baseline, the
mean age of participants was 27 years; 82% of them were from South Africa; 58% self-identified as Black
African; average education completed was 11.7 years. At three months, assignment to the lottery intervention
was associated with higher odds of returning for study visits (OR: 6.0; 95%CI: 2.45 to 14.7, p < 0.01), higher
condom use (OR: 4.5; 95%CI: 1.43 to 14.1; p < 0.05), and higher use of dual protection (OR: 3.16; 95%CI: 1.01
to 9.9; p < 0.05). Only 60% of the study population returned after three months and only 38% returned after
six months. Women who receive post-abortion care represent a neglected population with an urgent need for
HIV and pregnancy prevention. Dual protection is a critically important strategy for this population.
Lottery-based behavioural economics strategies may offer possible ways to increase dual protection use in this
population. Further research with larger samples, longer exposure time, and more sites is needed to
establish fully powered efficacy of lottery incentives for dual protection; using objective verification for
monitoring. DOI: 10.1080/09688080.2018.1510701
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1. Introduction
In South Africa, where over 6.4 million people are
living with HIV,1 supporting women’s sexual and
reproductive health includes supporting their
desires to avoid or delay pregnancy, while also
reducing their chances of HIV infection and trans-
mission.2 Dual protection, or the simultaneous
prevention of both pregnancy and HIV/STIs, is a
policy priority in recognition of the high rates of
sexually transmitted infections (STIs), including
HIV, as well as unintended pregnancy rates.3–5
Dual protection occurs via (a) correct and consist-
ent use of a condom alone (because appropriate
condom use can prevent both HIV and pregnancy),
or (b) via dual method use (DMU) which is correct
and consistent use of a condom/barrier method,
plus correct and consistent use of another effective
method of contraception, including long-acting
reversible contraception (LARC).2
In Southern Africa, 55% of pregnancies in
women aged 15–44 are unintended.6 Young
women in South Africa face a high risk of unin-
tended pregnancy. By age 18, 19% of women
have been pregnant, a figure that rises to 43% at
age 21, and 72% by age 25.7 Incorrect or inconsist-
ent use of contraception is common. Male partners
often oppose contraceptive use and access to ser-
vices can be limited, particularly in the teenage
years. Unprotected sex resulting in unintended
pregnancy also places women at risk for STIs,
including HIV infection. Women are disproportio-
nately affected by South Africa’s HIV epidemic,
with 23% of women (ages 15–49) HIV-infected.1
At 39%, pregnant women have the highest HIV
infection levels compared to other sub-popu-
lations.8 Moreover, pregnancy increases the risk
of vertical transmission of HIV/STIs.9 Use of effec-
tive contraception is thus critically important for
women wishing to avoid pregnancy, as is dual pro-
tection to prevent transmission or acquisition of
HIV/STIs.10–12 Since 2014, the National Depart-
ment of Health encourages the use of other long-
acting reversible hormonal contraception, in
addition to hormonal injectable contraception
(the etonogestrel contraceptive implant and
intrauterine devices), together with condoms, for
dual protection.13
Conditional lottery incentives, whereby partici-
pants have a chance to win a prize if they fulfil
some protective requirement, have proven effec-
tive in various realms of public health,14 and
they may also help in the uptake of HIV prevention
behaviours. For example, conditional lotteries cre-
ated excitement and renewed interest in HIV test-
ing and counselling among automotive workers
in two industrial plants in South Africa.15 Most sig-
nificantly, a lottery rewarding staying free of new
curable STIs was effective at reducing HIV inci-
dence among a heterosexual adult, rural popu-
lation in Lesotho.16
Behavioural economics is a relatively new science
which combines features of economics and psychol-
ogy to address systematic biases in human behav-
iour.17 One of the main insights of behavioural
economics is that we, as humans, do not always
maximise our own “utility” or well-being in a
“rational” manner.18 That is, we do not necessarily
act in a way that would fully maximise our long-
term benefits. We may be present-biased or short-
sighted because we are more focused on our actions
in the very short term rather than on what may or
may not happen in the distant future. Another
important insight is that of salience: we tend to
make decisions based on information that has
been received more recently, or that has been
received from a particular source. Given that we
have started to understand these systematic
human biases,19 behavioural economics attempts
to address them with interventions to improve pub-
lic policies. Thus behavioural economic approaches
can have important implications for HIV prevention
and treatment.20,21
Behavioural economics can provide a frame-
work to explain why some women may not follow
through with their stated intentions to initiate and
particularly to continue using LARC and dual pro-
tection.22 First, life stressors can negatively affect
decision-making: for example, worries about per-
sonal finances can compromise the ability to
make decisions, and may compromise self-regu-
lation.23,24 Lotteries may help to address hidden
health-seeking costs, which are sometimes unaf-
fordable, due to factors such as transportation
costs or missed work time because of long waiting
times in clinics and the need for multiple clinic
appointments. Second, decisions for LARC may be
done in a “cold” (or calculating) state of mind,
while decisions about condom use may often be
decided in the heat of the moment.25 Thus, lot-
teries may help to counterbalance the different
weights given to the decisions in different “hot/
cold” states. Third, undue weight to small probabil-
ities is another behavioural economics concept
that has been applied to lotteries. The proposed
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intervention – a lottery conditional on fulfilling
goals of dual protection to win a small monetary
prize – aims to turn around this common human
shortcoming and re-focus it toward health
benefits. Lotteries are popular around the world
because they generally present a small probability
of winning a large prize. Although the probability
of winning the large prize is only slightly greater
than zero, millions of people buy lottery tickets
every day. We seek to use this paradigm to help
women follow through their stated goals of health
promotion by using a lottery with a greater prob-
ability of winning.
Given many women’s dual desire to avoid preg-
nancy and HIV infection and transmission, and the
success of conditional lotteries in nudging individ-
uals towards healthier behaviours, we pilot tested
a behavioural economics innovation – the
Empower, Nudge Lottery – in combination with
best practices for contraceptive use and HIV/STI
prevention to promote dual protection (via DMU)
among women wishing to avoid a repeat
unintended pregnancy. Though incentives have
been used to promote contraception,26 to our
knowledge, lotteries have not been used, nor has
dual protection been measured as a specific
outcome.
2. Methods
We conducted a randomised controlled pilot as a
proof-of-concept to test a lottery to promote dual
protection among young women seeking post-abor-
tion care in South Africa. After post-abortion care,
women are regularly offered contraception, thus
facilitating the goals of the lottery trial. We followed
participants for six months individually (during May
2015–April 2016). We obtained written informed
consent from all participants. Institutional Review
Boards at the University of Cape Town, South Africa,
and at Brown University, Providence, RI, USA
approved all procedures. We registered the protocol
at ClinicalTrials.gov under identifier number
NCT02536612.
2.1. Experimental design and site
A total of 100 women who had recently experi-
enced an abortion were randomly assigned in a
1:1 ratio to one of two groups. Group 1 (control)
received only transport compensation (R100 each
time, ∼US$8 at the time of the intervention) for
study visits at enrolment and at months 3 and
6. Group 2 (intervention) received transport
compensation (R100 each time) for study visits at
enrolment and at months 3 and 6, plus the oppor-
tunity to enter a lottery (with a 50% chance of win-
ning R400, ∼US$33, each time, at months 3 and 6).
Participants in the intervention group had a
chance to receive: (a) one lottery ticket subject to
confirmation of the continued use of modern con-
traceptive methods at 3 months; and (b) another
lottery ticket subject to confirmation of dual pro-
tection use at 6 months.
At the initial clinic visit, in consultation with a
healthcare provider and unrelated to the study,
women selected a contraceptive method from
various options: injectable hormonal contracep-
tion (Depo-Provera or Nur-Isterate); implant;
intrauterine device (IUD); or oral contraceptives
(OCs). All participants received condoms (male
and female), and brief counselling/basic infor-
mation about dual protection from the project
nurse. Women who continued method use, as
determined by a clinical specialist, at the
month 3 visit, received their first lottery ticket.
(Being STI free was not a condition at three
months; this gave us more confidence in the
self-reported condom use outcome as it was
explicitly stated that condom use was in no way
tied to lottery eligibility at month 3). The second
ticket was provided at the end of the study
(month 6) to those with successful dual protec-
tion: those who had renewed (or not discontin-
ued) their contraception method, and who were
STI-free. (Syphilis served as a proxy for non-con-
dom use because of cost and ease of implemen-
tation. We did not expect to find many cases, but
we expected participants to use condoms more to
make sure they did not test positive. This was
another innovative use of the tendency to over-
weight small probabilities; the theory suggests
that a representative participant may have
thought: even if I know that few women contract
syphilis, I’ll still use condoms because I [overweight
small probabilities and] don’t want to lose my lot-
tery ticket. A urine pregnancy test was also admi-
nistered, though pregnancy status was not used
as conditionality at any point in the study.
The clinical study site was a public healthcare
facility in Cape Town, South Africa. This facility
has adequate space and administrative privacy
and is used frequently by post-abortion clients
(with referrals from a secondary hospital) as it pro-
vides a full range of contraceptive options. It also
has a history of close collaboration between
research and clinical staff.
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2.2. Eligibility and randomisation
Women, 18–40 years, presenting for post-abortion
family planning services were eligible to partici-
pate, regardless of HIV/STI status. Study partici-
pants had sought abortion services (both surgical
and medical). Medical abortions were performed
with Mifepristone at the clinic followed by Miso-
prostol at home. Surgical abortions, using manual
vacuum aspiration (MVA), were performed at the
clinic. Women who chose to receive injectables,
implant, or an IUD were eligible for the study;
those who received OCs were not (as objective
monitoring of daily pill use was deemed less feas-
ible). As of 2015, modern contraceptive prevalence
among married or in-union women, 15–49 years of
age in South Africa was reported to be 64.8%;
injectables accounted for 30.3% of contraceptive
prevalence, male condoms for 4.9%, IUDs for
1.1%, and implants with a negligible proportion
near 0%.27 Participants were approached while in
an observation/recovery area (after the medical
or surgical procedure had been completed, and
after they had chosen a contraceptive method for
future use). They underwent informed consent
procedures in a separate, private room (the Sup-
plementary Appendix has a blank informed con-
sent form). If they agreed to participate, they
filled out a brief baseline survey, and then they
agreed to return for 3- and 6-month follow-ups.
A statistical expert, independent from the study,
generated a random sequence and filled opaque
envelopes (to conceal the allocation) with cards
that said either “Lottery” or “No lottery.” After
enrolling a participant, the study research assistant
opened the next envelope and assigned the partici-
pant accordingly. Because knowledge of the inter-
vention (lottery) was a design feature, assignment
was unblinded after randomisation.
2.3. Rationale for design and eligibility
The justification for the study design and eligibility
criteria is as follows. First, we used a lottery rather
than a guaranteed payment scheme as an incen-
tive because we wanted to test specific behavioural
economic hypotheses; and most of the previous lit-
erature on incentives and contraception focused
on guaranteed payments.26 Some of the guaran-
teed payment schemes, such as conditional cash
transfers, however, have shown mixed results.28,29
One reason for some of the null findings in guaran-
teed schemes may be because of the complex
interactions with education,30 which has been
traditionally used as the conditionality. Thus, lot-
tery incentives may be innovative if they can be
tied directly to some verifiable outcome; and
they could be potentially more cost-effective.
Second, we targeted women who received post-
abortion care for enrolment because they are a
population that would be highly motivated to
take up contraception. Although this study popu-
lation may be non-representative of all young
South African women, it serves as a highly-at-
need population for whom this proof-of-concept
idea of lottery incentives for dual protection may
be beneficial.
2.4. Measures
The primary outcome was whether a lottery
increased return rates for the 3-month follow-up
study interview. Secondary outcomes were dual
protection and condom use. A study research
assistant conducted the survey for the assessment.
Condom use was assessed as part of a series of
options for the question: “Are you currently using
any method to delay or avoid getting pregnant?”
(See Appendix for selected questions). Dual protec-
tion use was assessed with the question: “Do you
currently practice ‘dual protection’, that is do you
use a male or female condom as well as a modern
contraceptive method (IUD, or injectable contra-
ceptive) to prevent STIs and pregnancy?” Explora-
tory outcomes included assessing the feasibility
of objectively measuring dual protection at 3 and
6 months via clinical examinations, as well as con-
ducting urine pregnancy tests and STI (syphilis)
tests as proxy marker for objectively verifying con-
dom use.
2.5. Statistical analysis
The main analysis presents the treatment effects at
3 and at 6 months. We estimated unadjusted odds
ratios (ORs) comparing control and intervention
groups in a logistic regression framework at 3
and 6 months separately.31 As sensitivity analyses,
we first included adjusted odds ratios (aOR) using
covariates including demographic and socio-econ-
omic characteristics. Given the experimental
design, regression adjustment is not really needed;
however, many researchers continue to use it.32,33
Second, to address factors related to loss to follow
up, we used marginal structural modelling using
each participant’s return visit history to derive
inverse probability of treatment weights
(IPTW).34,35 Finally, if we found an initial main
effect, and to explore potential effect differences
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at different times, we also used fully interacted
models with the main effect of the lottery interven-
tion, time (visit) dummies, and interaction terms
(intervention group × time) using a generalised
estimating equation (GEE) framework.36 We con-
ducted the analyses using Stata SE 15.1 (College
Station, TX) with xtgee and glm commands for
the GEE and generalised linear models using robust
standard errors clustered at the individual level.
2.6. Sample size and statistical power
The original sample size estimation was based on
the secondary outcome of dual protection. The
most recent nationally representative data we
found for the prevalence of dual protection
(18.6%) was from 2010.37 Relevant sub-regional
data showed dual protection prevalence between
14% and 33%.38 We hence assumed that about
20% would be using dual protection in our sample,
and that the effect size would be 0.3. Thus, we
needed 34 women per arm to detect differences
with 95% confidence and 80% power. The target
of 50 per arm allowed for loss-to-follow-up of
32%. All data were collected in paper surveys admi-
nistered by research assistant, double-entered into
EpiData (http://www.epidata.dk/) and imported to
Stata for analysis.
3. Results
A total of 178 women were assessed for eligibility,
of which 42 (24%) were not eligible and 36 (20%)
declined to participate. Thus, 100 participants
were enrolled, randomised, and included for sub-
sequent analyses (Figure 1). Only 60% of the
study population returned at 3 months and only
38% of the population returned after 6 months.
3.1. Baseline data
Table 1 shows that baseline socio-demographic
characteristics of study participants were similar
in the control and lottery groups prior to randomis-
ation. The mean age was 27 years; 69% had a
stable sexual partner (married/committed/regu-
lar); 82% were South African nationals; 58% self-
identified as Black African (while the rest were of
mixed race); 20% were students and the average
number of years of education was 11.7 years.
They lived in households composed of four people
on average; and were living in the same area for
almost a decade. On average, they had 7.6 basic
household items (out of 10), and the monthly earn-
ings were about US$130. The HIV positivity rate
was 17%. There were no statistically significant
differences in the intervention and control groups.
Table 2 shows that self-reported sexual behav-
iour and stated demand for contraception was
also similar between control and lottery groups.
Among the 69 participants (69%) with stable sex
partners, more than a fourth (26%) were married,
41% described their relationship as “serious/com-
mitted” and a third (33%) said they had a regular
boyfriend. Among this group, almost a fourth
(23%) had sexual activity several times per week,
almost half (49%) had sexual activity weekly and
about a fifth (19%) had sex on a monthly basis.
More than half of this group (54%) stated that
they use condoms only “sometimes” while more
than a third (34%) said they never use condoms.
For most of the women (82%), the current ter-
mination of pregnancy (ToP) was their first abor-
tion; however, for almost a fifth (18%) it was
their second (or higher number) abortion. After
the current ToP, most of them (51%) chose an
injectable contraceptive (Depo-Provera), a third
(33%) chose the implant, followed by another
injectable (Nur-Isterate) (11%), and the IUD (7%).
The majority (89%) agreed or strongly agreed that
the lottery intervention would help them to con-
tinue using the contraceptive of choice that they
were planning to use.
3.2. Preliminary efficacy of lottery intervention
Table 3 presents the effects of the intervention on
primary and secondary outcomes. At months 3 and
6 (in the last two columns), the primary outcome
(returning for study interview) shows ORs greater
than 1 for the two follow-ups. In particular, the lot-
tery group was more than 6 times more likely to
return at 3 months than the control group (OR:
6.0, 95%CI: 2.45 to 14.7, p< 0.01) and over 5
times more likely to return at 6 months (OR:
5.09, 95%CI: 2.09 to 12.4, p< 0.01). The lottery
group was also over 4 times more likely to use con-
doms at 3 months (OR: 4.5, 95%CI: 1.43 to 14.1, p
< 0.05); and over twice as likely to do so at 6
months, (OR: 2.5, 95%CI: 0.57 to 11.1), though
the latter was not statistically significant. Finally,
we also observed significant improvements in
dual protection use at 3 months, with the lottery
group being over 3 times more likely to be using
dual protection than the control group (OR: 3.16,
95%CI: 1.01 to 9.91, p< 0.05); and also more likely
to do so at 6 months (OR: 1.3, 95%CI: 0.31 to 5.67)
though the latter was not statistically significant.
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3.3. Sensitivity analyses
The sensitivity analyses did not qualitatively
change the main results, and also suggested
increased dual protection and condom use in the
lottery group. We summarise the results below
with detailed tables shown as Supplementary
Materials.
3.3.1. Regression adjustment
Appendix Table A (see Supplementary Material)
presents adjusted odds ratios (aORs) controlling
for age, nationality, race, student status, schooling,
household size, years living in the area, an asset
index (as a proxy for wealth), monthly earnings
(to measure income), and HIV status. The lottery
group was more than 9 times more likely to return
at 3 months than the control group (aOR: 9.08, 95%
CI: 3.32 to 27.8, p< 0.01); and almost 6 times more
likely to return at 6 months (aOR: 5.94, 95%CI: 2.19
to 16.1, p< 0.01). The lottery group was also
almost 9 times more likely to use condoms at 3
months (aOR: 8.85, 95%CI: 2.17 to 63, p< 0.01);
and almost twice as likely to do so at 6 months,
(aOR: 1.81, 95%CI: 0.20 to 16.0), though the latter
was not statistically significant. Finally, we also
observed significant improvements in dual protec-
tion use at 3 months, with the lottery group being
over 3 times more likely to be using dual protec-
tion than the control group (aOR: 3.91, 95%CI:
0.89 to 17.2, p< 0.05); yet slightly less likely to
do so at 6 months (OR: 0.96, 95%CI: 0.14 to 6.76)
though the latter result was not statistically
significant.
3.3.2. Inverse probability weighting
Appendix Table B (see Supplementary Material) pre-
sents inverse-probability-weighted (IPW) adjusted
odds ratios controlling for age, nationality, race,
student status, schooling, household size, years
living in the area, an asset index (as a proxy for
wealth), monthly earnings (to measure income),
and HIV status. The lottery group was almost
8 times more likely to return at 3 months than
the control group (IPW aOR: 7.94, 95%CI: 2.62 to
Figure 1. Flow of participants for Empower Nudge Lottery initial pilot study
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24, p< 0.01); and almost 4 times more likely to
return at 6 months (IPW aOR: 3.82, 95%CI: 0.80 to
18.2, p< 0.10). The lottery group was also over 9
times more likely to use condoms at 3 months
(IPW aOR: 9.83, 95%CI: 1.32 to 72.9, p< 0.01);
and over 4 time more likely to do so at 6 months,
(IPW aOR: 4.19, 95%CI: 0.44 to 40), though the latter
was not statistically significant. Finally, we also
observed significant improvements in dual protec-
tion use at 3 months, with the lottery group being
over 3 times more likely to be using dual protection
than the control group (IPW aOR: 3.94, 95%CI: 0.80
to 19.3, p< 0.10); and also more likely to do so at 6
months (IPW OR: 2.29, 95%CI: 0.24 to 22.3) though
the latter result was not statistically significant.
3.3.3. Effects-by-time
Appendix Table C (see Supplementary Material)
summarises the effects-by-time results using fully
interacted effects-by-time models with main
effects and interactions for primary and secondary
outcomes to explore differential effects at specific
times. The main effect was large and significant
for returning for visit interview with OR = 5.091
(p< 0.01) and aOR = 5.801 (p< 0.01). Importantly,
the characteristics of those who returned for clinic
visit interviews were similar than those who did
not; we found no significant differences in the
main socio-demographic indicators, with the
exception of race: Black Africans were 2.9 times
more likely to return for the study interview (col-
umn 2). The 3-month-by-visit interactions were sig-
nificant for condom use and dual protection. In the
unadjusted model for condom use (column 3), the
3-month × Lottery interaction had OR = 9.085 (p
< 0.01); and the results were similar in the
adjusted model (column 4) with aOR = 9.5 (p<
0.01). Likewise, in the unadjusted model for dual
protection (column 5), the 3-month × Lottery inter-
action had OR = 10.02 (p< 0.10), and the results
were large also in the adjusted model (column 6)
with aOR = 13.36 (p< 0.05). The 6-month-by-visit







Age in years, mean (SD) 26.6 (6.2) 27.2 (5.5) 26.9 (5.9) 0.62
Stable partner 36 (72) 33 (66) 69 (69) 0.52
South African 42 (84) 40 (80) 82 (82) 0.61
Black African 27 (54) 31 (62) 58 (58) 0.47
Student 12 (24) 8 (16) 20 (20) 0.32
Highest school grade completed, mean (SD) 11.9 (1.8) 11.5 (1.8) 11.7 (1.8) 0.31
Household size, mean (SD) 4.14 (1.94) 4.02 (1.62) 4.08 (1.78) 0.74
Years living at current area, mean (SD) 10.52 (10.70) 9.24 (10.51) 9.88 (10.60) 0.55
Wealth based on asset indexb, mean (SD) 7.86 (2.08) 7.34 (2.32) 7.60 (2.21) 0.24
Monthly earnings (US $), median,
interquartile range
133 (93–177) 130 (86–163) 130 (90–168) 0.60
HIV-positive 6 (12) 11 (22) 17 (17) 0.19
Notes: Table presents number, n, and percentage (%), unless otherwise noted.
aChi-squared test conducted for binary variables and analysis of variance for continuous variables.
bWealth was measured using an asset index, defined as the sum of affirmative responses to questions about own-
ership of 10 household items.
Earnings data were transformed from South African Rand at an average exchange rate of 12 Rand per US $.
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Involved in sexual relationship 36 (72) 33 (66) 69 (69) 0.52
Type of partner
Married/permanent 11 (31) 7 (21) 18 (26) 0.38
Serious/committed 16 (44) 12 (36) 28 (41) 0.49
Regular boyfriend 9 (25) 14 (42) 23 (33) 0.12
Regularity of sexual activity
Daily 0 (0) 1 (3) 1 (1) 0.29
Several times per week 10 (28) 6 (18) 16 (23) 0.34
Weekly 20 (56) 14 (42) 34 (49) 0.28
Monthly 3 (8) 10 (30) 13 (19) 0.02
Less than once per month 3 (8) 2 (6) 5 (7) 0.72
Condom use regularity with partner
Always 5 (14) 3 (9) 8 (12) 0.51
Sometimes 20 (57) 17 (52) 37 (54) 0.64
Never 10 (29) 13 (39) 23 (34) 0.35
Partner’s feelings about condom use
Supports condom use 13 (36) 11 (33) 24 (35) 0.80
He doesn’t like it 23 (64) 22 (67) 45 (65) 0.81
Number of abortions
One (current ToP)b 42 (84) 40 (80) 82 (82) 0.60
Two or more 8 (16) 10 (20) 18 (18) 0.60
Contraception method to be used
Intra-uterine device (IUD) 3 (6) 4 (8) 7 (7) 0.72
Injection: Depo-Provera 28 (56) 23 (46) 51 (51) 0.27
Injection: Nur-Isterate 5 (10) 6 (12) 11 (11) 0.78
Implant 15 (30) 18 (36) 33 (33) 0.57
(Continued)
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interactions were marginally significant for con-
dom use and non-significant dual protection. Not
surprisingly, higher earnings are associated with
higher condom use and dual protection. Of note,
HIV-positive status is significantly associated with
higher condom use [aOR = 7.4 (p < 0.01)], though
non-significantly associated with higher dual pro-
tection [aOR = 2.4].
3.3.4. Exploratory outcomes
In terms of the exploratory outcomes, objective
verification of contraception method (by clinician
observation) was possible for about a fourth of
the lottery participants (13/50 = 26%) and a sixth
of the control group (8/50 = 16%), whose main con-
traception provider was the clinical site. In
addition, the STI results (for syphilis) as well as
the pregnancy results were not analysed because
of low cell size: there was only one case of syphilis
(in the control group), and no documented cases of
pregnancy.
4. Discussion
This is the first pilot trial, to our knowledge, docu-
menting the preliminary efficacy of a lottery inter-
vention to promote sustained use of dual
protection among young women intending to
avoid pregnancy in South Africa. The sample’s
mean age of 27 years with a 17% HIV positivity
rate is reflective of the most affected populations
in South Africa, the country with the largest HIV
epidemic in the world. Compared to the control
group, women in the intervention group who
had the opportunity to win a lottery prize were
more likely to return to study visits, use condoms
and use dual protection methods for the preven-
tion of unwanted pregnancies and HIV infection
at the 3-month follow-up. There was a signal at 6
months that follow-up interviews were more likely,
but the condom use and dual protection results
were no longer significant, possibly because of
the smaller sample size due to loss-to-follow-up.
This pilot trial shows short-term preliminary
efficacy to nudge young women receiving post-
abortion care in South Africa to use dual protection
methods using conditional lottery incentives. Simi-
lar lottery approaches have been used in the pre-
vention of HIV/STIs in other settings.39–41
Notably, a study in Lesotho showed that a lottery
ticket, conditional on negative test results for
STIs, was associated with lower HIV incidence.16
Previous experiences in South Africa and else-
where, suggest that conditional incentive policies
should be informed by carefully conducted
research, and ethical oversight.42 Finding ways to
ensure choice in the absence of coercion is essen-
tial. As part of this, incentive-based interventions
should be built upon best practices for contracep-
tive care, including informed decision-making,
expanded choice, non-coercion, and human rights.








Likelihood of stopping contraception use in next 6 months
Not at all likely 46 (92) 41 (82) 87 (87) 0.14
Don’t know 4 (8) 9 (18) 13 (13) 0.14
The lottery can help continue using contraceptive you are planning to use
Strongly agree 6 (12) 7 (14) 13 (13) 0.77
Agree 37 (74) 39 (78) 76 (76) 0.64
Disagree 7 (14) 4 (8) 11 (11) 0.34
Notes: Table presents number, n, and percentage (%), unless otherwise noted.
aChi-squared test conducted for binary variables and analysis of variance for continuous variables.
bToP = termination of pregnancy.
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promise to support and empower women in
achieving their goals.
This study was designed carefully to adhere to
the ethical principles outlined above. Most signifi-
cantly, choice to use contraception and choice of
method occurred outside of, and prior to, the
study. Women, in consultation with their clinical
care providers, made an informed decision to use
a long-acting reversible contraception option;
thus, the lottery served only as an additional tool
to support them in fulfilling their intention. Fur-
thermore, by choosing women who were receiving
post-abortion care, we targeted a population of
women who did not want to carry a pregnancy to
term, and who, through opting to use long-acting
contraception following an abortion, were highly
motivated to take up contraception. Designing an
intervention to align with “revealed preferences,”
as we do here, offers one way for lottery incentives
to avoid coercion. Other economic-based interven-
tions should be assessed similarly from an ethics
perspective, and choose carefully the
conditionality.43,44
These exploratory, proof-of-concept findings
highlight the critical need for innovative interven-
tions using behavioural economic insights to
curtail the negative effects of unwanted pregnancy
and HIV infection in low-resource settings. Partici-
pants’ knowledge of modern contraception was
high (>70%), but actual use was inconsistent.
Nevertheless, a large majority (89%) agreed that
an incentive-based intervention would motivate
them to continue contraceptive use over time,
indicating overall enthusiasm for the intervention
(data from project questionnaire, not shown). Sur-
prisingly, HIV status was not associated with return
for study visits although previous evidence suggests
that HIV status is associated with increased contact
with various healthcare providers.38,45 Neverthe-
less, there are different demands for dual protec-
tion from an HIV-positive versus HIV-negative
population. Although HIV-positive women had
higher likelihood of condom use –in line with rec-
ommended preventative actions– HIV status did
not affect dual protection. This may be reflective
of continued and strong childbearing desire and/
or fertility for women who are HIV-positive and
receiving ART.9
While this study assesses return at the 3-month
study interview and demonstrates that conditional
lotteries may lead to differential loss-to-follow-up,
in the current context of dual protection, this
Table 3. Unadjusted effects of the intervention on primary and secondary outcomes
Control, N= 50 Lottery, N= 50 Effect estimates
Unadjusted, n (%) Unadjusted, n (%) 3-month 6-month






50 (100) 20 (40) 10 (20) 50 (100) 40 (80) 28 (56) 6.00*** 5.09***
(2.45 to 14.7) (2.09 to 12.4)
Condom use 11 (22) 8 (40) 5 (50) 6 (12) 30 (75) 20 (72) 4.50** 2.50
(1.43 to 14.1) (0.57 to 11.1)
Dual
protection
3 (6) 6 (30) 5 (50) 1 (2) 23 (58) 16 (57) 3.16** 1.33
(1.01 to 9.91) (0.31 to 5.67)
Notes: Table reports effects estimates using odds ratio (OR) from logistic regression using the control group as the refer-
ence category, and 95% confidence interval (CI).
*p< 0.10, **p< 0.05, ***p< 0.01.
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return for clinic visits is also an important proxy for
LARC, suggesting that lotteries have the potential
to influence continued use of dual protection
methods. Correct and sustained use of dual protec-
tion and LARC – which require periodic clinic vis-
its– continue to be important policy goals to
expand choice.3
4.1. Long-term costs and feasibility
One of the major concerns of conditional incen-
tives is that they may increase adherence in the
short term while the reward is offered, but they
may fail to address the underlying motivations
behind health choices and thus may not be suc-
cessful over time.21 Further research is thus
needed on lottery incentives as a longer-term strat-
egy, including the feasibility of scaling up such an
intervention as well as the costs and cost-
effectiveness.
4.2. Limitations
There were several limitations. First, we collected
syphilis data but the incidence rate was low,
which limited our ability to use STIs as a proxy
for condom use. In future work, data should be
collected on other STIs as well including: Chlamy-
dia, gonorrhoea and trichomonas vaginalis.
Second, the loss-to-follow-up (LTFU) rates were
high, despite repeated attempts via email and
text (WhatsApp) to contact the participants and
ask them to return for study visits. This may be
reflective also of high migration rates.46 Yet for
most participants, the post-abortion clinical site
was not the site of their regular care, which may
have meant that the costs of returning to this
specialised clinical site were higher than those
they might have experienced if follow-up had
occurred elsewhere, which should be a consider-
ation in future work. Further, relying on a popu-
lation of women receiving post-abortion care,
who have chosen long-acting contraception, pro-
vides a focused evaluation of lotteries among
women with a demonstrated strong preference
for contraception. However, this study population
is not representative of all women who might be
interested in dual protection. Future trials may
need less restrictive samples and should use tools
to link various health clinic databases at the local
and regional levels to allow for more timely and
objective verification of contraception use. Cash
upfront for transport to the clinic (rather than com-
pensation after the fact) may have reduced LTFU.
Third, the sample size was small. The initial effect
size, nevertheless, was large and it provides an
encouraging signal and initial proof-of-concept.
Finally, the short duration of the pilot trial (6
months) implied that we could not observe the dis-
continuation of longer duration LARCs (such as the
implant), and future trials should consider longer
periods of follow-up to help provide insight on
across methods, including long- and short-term
responses.
5. Conclusion
Larger scale studies, with more participants fol-
lowed for longer periods, are needed to fully evalu-
ate the efficacy of this type of behavioural
economics approach for increasing the use of
dual protection methods among women at high
risk of HIV acquisition and unwanted pregnancy.
Conditional lottery incentives tied to dual protec-
tion may have public health and policy develop-
ment implications beyond South Africa, too. The
preliminary efficacy results on lottery rewards
designed to support contraceptive use and dual
protection point to the value of additional research
with larger samples, in multiple sites, over a longer
period of time. There will be value as well in learn-
ing more from women directly, through in-depth
interviews, about how they experienced the behav-
ioural economic lottery intervention.
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Résumé
L’objectif de cette étude est de mesurer l’efficacité
préliminaire d’une intervention pilote, fondée sur
l’économie comportementale, destinée à augmenter
l’observance d’une double protection (utilisation
simultanée d’une contraception moderne efficace
et d’une méthode barrière comme le préservatif)
pour se protéger contre le VIH, d’autres infections
sexuellement transmissibles et les grossesses non
désirées. De 2015 à 2016, 100 femmes âgées de
18 à 40 ans qui avaient bénéficié de soins après
avortement au Cap, Afrique du Sud, ont été recru-
tées pour Empower Nudge, un essai randomisé con-
trôlé qui souhaitait tester une intervention incitative
avec loterie, conçue de façon à augmenter la double
protection. Au début de l’essai, l’âge moyen des par-
ticipantes était de 27 ans ; 82% d’entre elles étaient
originaires d’Afrique du Sud ; 58% s’identifiaient
elles-mêmes comme Africaines noires ; la durée
moyenne d’études achevées était de 11,7 ans.
Trois mois après, la participation à l’intervention
avec loterie était associée à des probabilités plus éle-
vées de retour pour les visites d’étude (RC : 6,0 ; 95%
IC : 2,45 à 14,7, p<0,01), un emploi accru du préser-
vatif (RC : 4,5 ; 95% IC : 1,43 à 14,1 ; p <0,05) et une
utilisation supérieure de la double protection (RC :
3,16 ; 95% IC : 1,01 à 9,9 ; p<0,05). Seulement
60% des femmes faisant l’objet de l’étude sont rev-
enues après trois mois et à peine 38% après six
mois. Les femmes qui ont reçu des soins après avor-
tement représentent une population négligée qui a
besoin de toute urgence de mesures de prévention
du VIH et des grossesses, et pour qui la double pro-
tection est une stratégie capitale. Les stratégies écon-
omiques comportementales basées sur une loterie
peuvent donner des moyens d’améliorer le recours
à une double protection parmi cette population.
De nouvelles recherches avec des échantillons plus
vastes, un temps d’exposition plus long et davantage
de sites sont nécessaires afin d’établir l’efficacité
totale des mesures d’incitation à base de loterie
pour la protection double, en utilisant une vérifica-
tion objective pour le suivi.
Resumen
El objetivo de este estudio es medir la eficacia
preliminar de una intervención piloto, basada
en la economía conductual, para aumentar la
adherencia a la doble protección (uso simultáneo
de un anticonceptivo moderno eficaz y un método
de barrera, como un condón, para proteger con-
tra el VIH, otras infecciones de transmisión sexual
y el embarazo no intencional). Entre 2015 y 2016,
100 mujeres de 18 a 40 años de edad, que busca-
ban atención postaborto en Ciudad del Cabo,
Sudáfrica, fueron reclutadas para participar en
Empower Nudge, un ensayo controlado aleatori-
zado para probar una intervención de incentivo
de lotería diseñada para aumentar el uso de
doble protección. En la línea de base, la edad
media de las participantes era de 27 años; el
82% provenía de Sudáfrica; el 58% se identificó
como Negra Africana; el nivel de escolaridad pro-
medio era de 11.7 años. Después de tres meses, la
asignación a la intervención de lotería fue aso-
ciada con mayor probabilidad de regresar para
las visitas del estudio (RM: 6.0; IC de 95%: 2.45
a 14.7, p < 0.01), mayor uso de condones (RM:
4.5; IC de 95%: 1.43 a 14.1; p < 0.05) y mayor
uso de doble protección (RM: 3.16; IC de 95%:
1.01 a 9.9; p < 0.05). Solo el 60% de la población
del estudio regresó después de tres meses y solo el
38% regresó después de seis meses. Las mujeres
que reciben atención postaborto representan a
una población desatendida con una necesidad
urgente de prevención de VIH y embarazo. La
doble protección es una estrategia de fundamen-
tal importancia para esta población. Las estrate-
gias de economía conductual basada en la
lotería podrían ofrecer posibles maneras de
aumentar el uso de doble protección en esta
población. Se necesitan más estudios de investiga-
ción con mayores muestras, más tiempo de expo-
sición y más lugares de estudio para establecer la
plena eficacia de los incentivos de lotería para
usar doble protección, utilizando verificación
objetiva para el monitoreo.
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